EUCODIS Bioscience
EUCODIS Bioscience | Smart enzyme solutions.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
EUCODIS Bioscience, now operating as Biosynth, was established in 2007 in Vienna, Austria. The company focuses on enzyme engineering and manufacturing, catering to a global client base in the pharmaceutical, biotechnology, diagnostics, fine chemicals, food, and cosmetics industries.
The business model centers on providing both off-the-shelf enzyme products and highly customized enzyme solutions. Revenue is generated through the sale of its portfolio of over 50 enzymes and through providing services in enzyme development, bioprocess creation, and industrial-scale manufacturing of target proteins under ISO9001:2015 standards. The company's service offerings cover the full spectrum of biocatalysis, from enzyme identification and screening to strain development and bioprocess upscaling. This dual approach of product sales and tailored services allows the company to meet a wide range of customer needs, from research applications to industrial production.
EUCODIS Bioscience utilizes proprietary technologies for enzyme engineering, such as "in vivo recombination," to develop novel biocatalysts. Its product line includes a diverse range of enzymes like lipases, beta-lactamases, peroxidases, and nitrile hydratases. These enzymes serve as alternatives to traditional chemical synthesis steps, enabling reactions at lower temperatures and reducing energy and chemical consumption. A notable milestone was the acquisition of EUCODIS Bioscience by Biosynth in August 2022, a move intended to broaden Biosynth's biological product offerings and integrate EUCODIS's enzyme expertise with Biosynth's capabilities in chemical synthesis. This integration followed years of collaboration between the two companies on various innovation projects. Prior to its acquisition, the company had raised capital from institutional venture funds and private investors.
Keywords: enzyme engineering, biocatalysis, industrial enzymes, recombinant proteins, bioprocess development, specialty chemicals, pharmaceutical enzymes, custom enzymes, biotechnology manufacturing, lipases, beta-lactamases, peroxidases, protein production, microbial fermentation, strain development, enzyme screening, fine chemicals, diagnostics enzymes, cosmetics ingredients, food and feed enzymes